Records containing: HIV Infections
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-12-23Efecto de la Isoprinosina en Pacientes Con infección Por VIH y Carga Viral Entre > 50 y < 200 Copias/mL de la Unidad de atención de PVV Del Hospital Enrique Garcés en Quito, Ecuador Durante el año 2019.
-
CLINICAL_TRIALS study record update · 2019-12-19Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa
-
CLINICAL_TRIALS study record update · 2019-12-18Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors
-
CLINICAL_TRIALS study record update · 2019-12-17A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP In Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection
-
CLINICAL_TRIALS study record update · 2019-12-17The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory, Pilot Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-12-17A Natural History Study of HIV Acquired in Infancy or Childhood
-
CLINICAL_TRIALS study record update · 2019-12-16VRC 012: A Phase I Clinical Trial of the Safety and Immunogenicity of an HIV-1 Adenoviral Vector Serotype 35 Vaccine: Dose Escalation as a Single Agent and Prime-Boost Schedules With an HIV-1 Adenoviral Vector Serotype 5 Vaccine in Uninfected Adults
-
CLINICAL_TRIALS study record update · 2019-12-12A Study of the Effects of Potent Anti-HIV Therapy on Parameters Hypothesized to be Related to the Pathogenesis of Kaposi's Sarcoma (KS) in HIV-Infected Individuals
-
CLINICAL_TRIALS study record update · 2019-12-12ClinicalTrials.gov study NCT00110331
-
CLINICAL_TRIALS study record update · 2019-12-09A Phase IIa Randomized, Placebo Controlled, Double Blinded Study to Evaluate the Safety and Immunogenicity of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2019-12-09A 2-Part, Phase I, Single-Dose, 3-Period Crossover Relative Bioavailability Study of a Pediatric TRIUMEQ Dispersible Tablet and Pediatric Dolutegravir and Lamivudine (DTG/3TC) Fixed Dose Combination Dispersible Tablet Formulations as Compared With Adult Tablets in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2019-12-05Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours
-
CLINICAL_TRIALS study record update · 2019-12-05Efficacy and Safety of High-dose Ribavirin (1600 mg/d) Boosted With Epoetin β (450 IU/kg/wk) in HIV/HCV Coinfected Patients Not Responding to Previous Treatment Regimens
-
CLINICAL_TRIALS study record update · 2019-12-05Prospective, Open Label and Randomized Clinical Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients
-
CLINICAL_TRIALS study record update · 2019-12-05Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2019-12-05Screening Subjects for HIV Vaccine Research Studies
-
CLINICAL_TRIALS study record update · 2019-12-05Hepatitis B and HIV Co-Infection in Uganda
-
CLINICAL_TRIALS study record update · 2019-12-05Clinical Pilot, Open, Comparative and Randomized Trial to Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy
-
CLINICAL_TRIALS study record update · 2019-12-05Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
-
CLINICAL_TRIALS study record update · 2019-12-04HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
-
CLINICAL_TRIALS study record update · 2019-12-04Clinical Pilot Trial to Evaluate the Influence of Nevirapine in Exposure to Atazanavir in Steady State Equilibrium in HIV-infected Adult Patients.
-
CLINICAL_TRIALS study record update · 2019-12-04Open-label, Comparative and Randomised Pilot Study to Evaluate the Efficacy and Safety of Saquinavir/Ritonavir in Single Therapy vs Standard HAART Therapy as Maintenance Therapy.
-
CLINICAL_TRIALS study record update · 2019-12-04Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
-
CLINICAL_TRIALS study record update · 2019-12-04Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
-
CLINICAL_TRIALS study record update · 2019-12-04Cross-sectional Study for the Characterisation of the Pharmacokinetic Parameters of Protease Inhibitors and Non-nucleoside Analog Reverse Transcriptase Inhibitors in the Spanish Population of HIV-infected Subjects